InsidersTradesSigma
Follow the 2cureX AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, 2cureX AB has logged 3 reports. Market capitalisation: €43.4m. The latest transaction was disclosed on 28 April 2026 (Purchase). Among the most active insiders: Juergen Kupper. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
€349,377
1 ops.
Buy Volume
€20,637
1 ops.
Sell Volume
28Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 April 2026
Declarations3 total
3,460,134 shares@ €0.1010.64% mcap100.0% of flowAktieISIN SE0010468124FI:A003X897-1
10,600 shares@ SEK 19.75100.0% of flowAktieISIN SE0010468124FI:A001P631-1
31,800 shares0WarrantFI:A001P350-1
3 of 3 declarations
About 2cureX AB
2cureX AB is a company focused on developing diagnostic solutions for cancer treatment. It operates in the healthcare and pharmaceutical sector, listed on the XSTO market.